Cargando…

Recurrent isolated optic neuritis: A study on 22 patients

Background: Isolated relapsing optic neuropathy is a recurrent painful optic nerve inflammation without any sign of other demyelinating diseases such as multiple sclerosis (MS) or neuromyelitis optica (NMO) spectrum disorders, and the attacks are purely responsive to steroid therapy. Methods: Recurr...

Descripción completa

Detalles Bibliográficos
Autores principales: Arzani, Mahsa, Sahraian, Mohammad Ali, Rezaei, Hamed, Moghadasi, Abdorreza Naser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673985/
https://www.ncbi.nlm.nih.gov/pubmed/29114368
_version_ 1783276680855420928
author Arzani, Mahsa
Sahraian, Mohammad Ali
Rezaei, Hamed
Moghadasi, Abdorreza Naser
author_facet Arzani, Mahsa
Sahraian, Mohammad Ali
Rezaei, Hamed
Moghadasi, Abdorreza Naser
author_sort Arzani, Mahsa
collection PubMed
description Background: Isolated relapsing optic neuropathy is a recurrent painful optic nerve inflammation without any sign of other demyelinating diseases such as multiple sclerosis (MS) or neuromyelitis optica (NMO) spectrum disorders, and the attacks are purely responsive to steroid therapy. Methods: Recurrent isolated optic neuritis (RION) was diagnosed in patients who presented with at least two disseminating episodes of optic neuritis, and negative clinical, para-clinical, and radiological features of the demyelinating, infiltrative and vasculitis disorders involving optic nerve. The patients were assigned into two groups, chronic recurrent isolated optic neuritis (CRION) entailing patients with steroid dependent attack of optic neuritis and RION patients without steroid dependent attack of optic neuritis. They were monitored over a median of 4.0 ± 2.5 years. Results: There were 16 women and six men with CRION and RION; with the median age of 31.7 ± 9.8 (29.3 ± 9.7 for women and 37.7 ± 7.7 for men). The women to men ratio was 2.6:1. The mean optic neuritis attack was 2.95 ± 1.32 in total. Eight patients were RION while 14 patients fulfilled CRION criteria and took long term immuno-suppressive drugs. In their follow-up, 4 out of 14 CRION cases (28.5%) showed clinical and concordant para-clinical features of NMO spectrum disorder. The analysis of demographic data showed that the average number of ON attacks in CRION patients (3.79 ± 2.32) was significantly more than the average in patients with RION (2.25 ± 0.46, P = 0.02). Conclusion: CRION is a disease which requires aggressive glucocorticoid and long-term immunosuppressive therapy to restore visual acuity.
format Online
Article
Text
id pubmed-5673985
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-56739852017-11-07 Recurrent isolated optic neuritis: A study on 22 patients Arzani, Mahsa Sahraian, Mohammad Ali Rezaei, Hamed Moghadasi, Abdorreza Naser Iran J Neurol Original Article Background: Isolated relapsing optic neuropathy is a recurrent painful optic nerve inflammation without any sign of other demyelinating diseases such as multiple sclerosis (MS) or neuromyelitis optica (NMO) spectrum disorders, and the attacks are purely responsive to steroid therapy. Methods: Recurrent isolated optic neuritis (RION) was diagnosed in patients who presented with at least two disseminating episodes of optic neuritis, and negative clinical, para-clinical, and radiological features of the demyelinating, infiltrative and vasculitis disorders involving optic nerve. The patients were assigned into two groups, chronic recurrent isolated optic neuritis (CRION) entailing patients with steroid dependent attack of optic neuritis and RION patients without steroid dependent attack of optic neuritis. They were monitored over a median of 4.0 ± 2.5 years. Results: There were 16 women and six men with CRION and RION; with the median age of 31.7 ± 9.8 (29.3 ± 9.7 for women and 37.7 ± 7.7 for men). The women to men ratio was 2.6:1. The mean optic neuritis attack was 2.95 ± 1.32 in total. Eight patients were RION while 14 patients fulfilled CRION criteria and took long term immuno-suppressive drugs. In their follow-up, 4 out of 14 CRION cases (28.5%) showed clinical and concordant para-clinical features of NMO spectrum disorder. The analysis of demographic data showed that the average number of ON attacks in CRION patients (3.79 ± 2.32) was significantly more than the average in patients with RION (2.25 ± 0.46, P = 0.02). Conclusion: CRION is a disease which requires aggressive glucocorticoid and long-term immunosuppressive therapy to restore visual acuity. Tehran University of Medical Sciences 2017-07-06 /pmc/articles/PMC5673985/ /pubmed/29114368 Text en Copyright © 2015 Iranian Neurological Association, and Tehran University of Medical Sciences This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Arzani, Mahsa
Sahraian, Mohammad Ali
Rezaei, Hamed
Moghadasi, Abdorreza Naser
Recurrent isolated optic neuritis: A study on 22 patients
title Recurrent isolated optic neuritis: A study on 22 patients
title_full Recurrent isolated optic neuritis: A study on 22 patients
title_fullStr Recurrent isolated optic neuritis: A study on 22 patients
title_full_unstemmed Recurrent isolated optic neuritis: A study on 22 patients
title_short Recurrent isolated optic neuritis: A study on 22 patients
title_sort recurrent isolated optic neuritis: a study on 22 patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673985/
https://www.ncbi.nlm.nih.gov/pubmed/29114368
work_keys_str_mv AT arzanimahsa recurrentisolatedopticneuritisastudyon22patients
AT sahraianmohammadali recurrentisolatedopticneuritisastudyon22patients
AT rezaeihamed recurrentisolatedopticneuritisastudyon22patients
AT moghadasiabdorrezanaser recurrentisolatedopticneuritisastudyon22patients